EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
EyePoint, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.44−2.55 (-85.28%)
Close on Oct 19, 2026
- Market cap
- $38.08K
- P/E (TTM)
- –
- Dividend yield
- –
EyePoint statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | EyePoint | Industry median |
|---|---|---|
| Market Cap | $37.93M | $229.23M |
| Enterprise Value | -$142.57M | $194.73M |
| PS Ratio | 13.60 | 3.14 |
| PB Ratio | 0.23 | 3.19 |
| P/TBV Ratio | 0.23 | 4.69 |
Enterprise value
| Measure | EyePoint | Industry median |
|---|---|---|
| EV / Sales | -51.12 | 2.93 |
Income (trailing twelve months)
| Measure | EyePoint | Industry median |
|---|---|---|
| Revenue | $2.79M | $102.39M |
| Operating Income | -$316.98M | -$4.31M |
| Net Income | -$306.64M | -$6.57M |
| EBITDA | -$314.38M | -$1.98M |
Margins
| Measure | EyePoint | Industry median |
|---|---|---|
| Operating Margin | -11365.2% | -6.04% |
| Profit Margin | -10994.7% | -10.5% |
| EBITDA Margin | -11272.0% | -2.67% |
| FCF Margin | -9726.8% | -0.30% |
Returns
| Measure | EyePoint | Industry median |
|---|---|---|
| Return on Equity (ROE) | -148.7% | -19.2% |
| Return on Assets (ROA) | -115.9% | -13.3% |
| Return on Capital Employed (ROCE) | -170.2% | -9.07% |
Growth
| Measure | EyePoint | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -94.6% | 8.85% |
| Revenue Growth (3Y CAGR) | -8.83% | 7.08% |
| Revenue Growth (5Y CAGR) | -1.85% | 11.8% |
Balance sheet
| Measure | EyePoint | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $180.50M | $37.33M |
| Net Cash (Debt) | $180.50M | $3.92M |
| Net Cash Per Share | $2.09 | $0.28 |
| Equity (Book Value) | $166.41M | $57.36M |
| Book Value Per Share | $1.93 | $2.81 |
| Tangible Book Value | $166.41M | $10.71M |
| Working Capital | $146.87M | $54.64M |
Financial position
| Measure | EyePoint | Industry median |
|---|---|---|
| Current Ratio | 4.50 | 2.50 |
| Quick Ratio | 4.30 | 1.54 |
Cash flow (trailing twelve months)
| Measure | EyePoint | Industry median |
|---|---|---|
| Operating Cash Flow | -$267.30M | -$653.46K |
| Capital Expenditures | -$3.98M | -$3.69M |
| Free Cash Flow | -$271.28M | -$835.02K |
| FCF Per Share | -$3.15 | -$0.02 |
Efficiency
| Measure | EyePoint | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.59 |
| Revenue Per Employee | $13.03K | $322.75K |
| Profits Per Employee | -$1.43M | -$52.11K |
| Employee Count | 214 | 197 |
Dividends and yields
| Measure | EyePoint | Industry median |
|---|---|---|
| Earnings Yield | -808.4% | -6.92% |
| FCF Yield | -715.1% | -0.62% |
Shares
| Measure | EyePoint | Industry median |
|---|---|---|
| Shares Outstanding | 86,212,100 | 44,856,700 |
| Shares Change (YoY) | 25.9% | 3.35% |
| Shares Change (QoQ) | 1.83% | 0.27% |
| Float | 85,382,900 | 36,934,400 |
| Shares Held by Insiders | 0.96% | 10.6% |
| Shares Held by Institutions | 107.7% | 63.5% |
Taxes
| Measure | EyePoint | Industry median |
|---|---|---|
| Income Tax | $136.00K | $1.52M |
Scores
| Measure | EyePoint | Industry median |
|---|---|---|
| Altman Z-Score | -11.31 | 1.95 |
| Piotroski F-Score | 2 | 5 |
Calculated by StockData from EyePoint's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.